News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
888,412 Results
Type
Article (89127)
Company Profile (556)
Press Release (798712)
Multimedia
Podcasts (255)
Webinars (39)
Section
Business (267191)
Career Advice (4169)
Deals (40064)
Drug Delivery (189)
Drug Development (91865)
Employer Resources (208)
FDA (18643)
Job Trends (17513)
News (399092)
Policy (40029)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (5)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (3)
2027 Genetown Elite (4)
2027 Genetown Standard (7)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (7)
Academia (3074)
Academic (2)
Accelerated approval (63)
ADA (50)
Adcomms (43)
Allergies (216)
Alliances (56991)
ALS (252)
Alzheimer's disease (2064)
Antibody-drug conjugate (ADC) (625)
Approvals (19078)
Artificial intelligence (970)
ASCO (345)
Autoimmune disease (407)
Automation (71)
Bankruptcy (409)
Best Places to Work (12635)
BIO (81)
Biologics (1)
BIOSECURE Act (23)
Biosimilars (273)
BioSpace Insights (240)
Biotechnology (337)
Bladder cancer (227)
Brain cancer (87)
Breast cancer (887)
Cancer (7037)
Cardiovascular disease (601)
Career advice (3611)
Career pathing (58)
CAR-T (408)
CDC (77)
Celiac Disease (3)
Cell therapy (1137)
Cervical cancer (60)
Clinical research (79707)
Collaboration (2578)
Commercialization (8)
Company closure (8)
Compensation (1680)
Complete response letters (121)
COVID-19 (3054)
CRISPR (133)
C-suite (1448)
Cystic fibrosis (173)
Data (9302)
Decentralized trials (3)
Denatured (98)
Depression (212)
Dermatology (117)
Diabetes (746)
Diagnostics (7736)
Digital health (77)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (496)
Drug pricing (248)
Drug shortages (39)
Duchenne muscular dystrophy (354)
Earnings (103413)
Editorial (82)
Employer branding (25)
Employer resources (178)
Events (139337)
Executive appointments (1282)
FDA (23115)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (25)
Frontotemporal dementia (37)
Funding (2103)
Gene editing (291)
Generative AI (100)
Gene therapy (895)
GLP-1 (1321)
Government (5578)
Grass and pollen (8)
Guidances (434)
Healthcare (21294)
Hematology (198)
HIV (110)
Huntington's disease (74)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (128)
Immunology and inflammation (382)
Immuno-oncology (126)
Indications (239)
Infectious disease (3475)
Inflammatory bowel disease (249)
Inflation Reduction Act (17)
Influenza (157)
Intellectual property (352)
Interviews (824)
IPO (18034)
IRA (61)
Job creations (5209)
Job search strategy (2876)
JPM (73)
Kidney cancer (27)
Labor market (131)
Layoffs (704)
Leadership (57)
Legal (10175)
Licensing (12)
Liver cancer (112)
Longevity (39)
Lung cancer (933)
Lymphoma (508)
Machine learning (70)
Management (69)
Manufacturing (1369)
Marketing (15)
MASH (235)
Medical affairs (1)
Medical device (15358)
Medtech (15595)
Mergers & acquisitions (23449)
Metabolic disorders (1928)
mRNA (287)
Multiple sclerosis (218)
NASH (24)
Neurodegenerative disease (563)
Neuropsychiatric disorders (139)
Neuroscience (3973)
Neurotech (2)
NextGen: Class of 2026 (7718)
Non-profit (5154)
Now hiring (89)
Obesity (912)
Opinion (386)
Ovarian cancer (260)
Pain (304)
Pancreatic cancer (386)
Parkinson's disease (447)
Partnered (45)
Patents (727)
Patient recruitment (895)
Peanut (73)
People (68429)
Pharmaceutical (81)
Pharmacy benefit managers (38)
Phase 1 (24613)
Phase 2 (34619)
Phase 3 (26037)
Pipeline (11369)
Policy (411)
Postmarket research (3561)
Preclinical (11033)
Press Release (72)
Prostate cancer (372)
Psychedelics (86)
Radiopharmaceuticals (394)
Rare diseases (1412)
Real estate (7467)
Recruiting (83)
Regulatory (30994)
Reports (84)
Research institute (2791)
Resumes & cover letters (655)
Rett syndrome (50)
RNA editing (32)
RSV (101)
Schizophrenia (204)
Series A (359)
Series B (264)
Service/supplier (16)
Sickle cell disease (136)
Special edition (34)
Spinal muscular atrophy (194)
Sponsored (55)
Startups (4379)
State (2)
Stomach cancer (21)
Supply chain (154)
Tariffs (105)
The Weekly (154)
Vaccines (1355)
Venture capital (149)
Weight loss (619)
Women's health (157)
Worklife (25)
Date
Today (128)
Last 7 days (723)
Last 30 days (2693)
Last 365 days (33499)
2026 (21038)
2025 (33213)
2024 (37865)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1301)
Alabama (107)
Alaska (7)
Arizona (432)
Arkansas (16)
Asia (52605)
Australia (9254)
California (15300)
Canada (4276)
China (1737)
Colorado (658)
Connecticut (678)
Delaware (472)
Europe (121346)
Florida (2317)
Georgia (496)
Hawaii (5)
Idaho (70)
Illinois (1332)
India (123)
Indiana (702)
Iowa (27)
Japan (659)
Kansas (150)
Kentucky (60)
Louisiana (66)
Maine (94)
Maryland (1834)
Massachusetts (11171)
Michigan (439)
Minnesota (857)
Mississippi (7)
Missouri (174)
Montana (37)
Nebraska (31)
Nevada (163)
New Hampshire (92)
New Jersey (4039)
New Mexico (37)
New York (4028)
North Carolina (2018)
North Dakota (11)
Northern California (7694)
Ohio (482)
Oklahoma (30)
Oregon (48)
Pennsylvania (2975)
Puerto Rico (33)
Rhode Island (55)
South America (1671)
South Carolina (93)
South Dakota (2)
Southern California (6047)
Tennessee (253)
Texas (2498)
United States (54573)
Utah (465)
Vermont (2)
Virginia (384)
Washington D.C. (88)
Washington State (1238)
West Virginia (4)
Wisconsin (169)
Wyoming (2)
There are 888,412 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Olympia Pharmaceuticals Advances Longevity Offerings With Advanced Injectable CoQ10 Formulation
August 12, 2026
·
3 min read
Press Releases
FDA Grants Breakthrough Device Designation to Freenome’s Blood-Based SimpleScreen™ Lung Cancer Screening Test
August 12, 2026
·
6 min read
Press Releases
Femasys Strengthens and Extends Global Patent Protection for FemBloc® with First Issued Blended Polymer Patents
August 12, 2026
·
5 min read
Press Releases
Ventripoint Expands Subscription Access for FDA-Cleared AI Cardiac Imaging
August 12, 2026
·
9 min read
Press Releases
Kyowa Kirin Introduces Family Outreach Initiative to Support Families Living with XLH
August 12, 2026
·
7 min read
Events
Register: The Insider’s Guide to Leveraging Podcasts, Webinars and Thought Leadership Programs
How do you turn podcasts, webinars and thought leadership programs into meaningful visibility for your organization or clients? Join BioSpace’s Managing Editor, Director of Insights and Vice President of Marketing for an inside look at how PR, communications and marketing teams can successfully leverage webinars, podcasts and integrated content campaigns to elevate executive voices, share industry expertise and engage key biotech and pharma audiences.
August 12, 2026
Rare diseases
Deaths reported after treatment with Neurocrine’s approved Prader-Willi drug
Reports of seven deaths in patients who had taken Neurocrine Biosciences’ Vykat and the official termination of Aardvark Therapeutics’ Phase 3 trial after cardiac complications marked a tough day for the Prader-Willi syndrome community.
August 12, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts
European customers can now subscribe to Sino Biological’s newsletter to receive a special gift and unlock access to EliteScience benefits.
August 12, 2026
·
2 min read
IPO
2026 IPO stock tracker: How newly public biotechs are performing
BioSpace
is launching an IPO dashboard to help the industry keep tabs on U.S. biotechs that have taken the public plunge in 2026.
August 12, 2026
·
1 min read
·
Gabrielle Masson
Psychedelics
Definium’s LSD asset beats analyst expectations in Phase 3 anxiety readout
It’s smooth sailing for Definium Therapeutics as the psychedelic biotech charts another win for its LSD candidate, this time in anxiety. The psychedelic previously notched a late-stage victory in depression.
August 12, 2026
·
4 min read
·
Gabrielle Masson
1 of 88,842
Next